ARTICLE | Clinical News
Lamivudine/zidovudine regulatory update
October 25, 2010 7:00 AM UTC
FDA granted tentative marketing approval for Strides' lamivudine/zidovudine for use in combination with other antiretrovirals to treat HIV-1 infection. The product is now eligible for purchase outside...